BioCentury | Jun 9, 2014
Company News

Opalia Pharma S.A., Recordati deal

...owns the remaining 10%. Opalia markets generic drugs in Tunisia (see BioCentury, July 29, 2013). Opalia Pharma S.A....
BioCentury | Jul 29, 2013
Company News

Opalia Pharma S.A., Recordati deal

...is subject to approval by Tunisian authorities. The companies could not be reached for details. Opalia Pharma S.A....
Items per page:
1 - 2 of 2
BioCentury | Jun 9, 2014
Company News

Opalia Pharma S.A., Recordati deal

...owns the remaining 10%. Opalia markets generic drugs in Tunisia (see BioCentury, July 29, 2013). Opalia Pharma S.A....
BioCentury | Jul 29, 2013
Company News

Opalia Pharma S.A., Recordati deal

...is subject to approval by Tunisian authorities. The companies could not be reached for details. Opalia Pharma S.A....
Items per page:
1 - 2 of 2